These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 18980634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders.
    Serretti A, Olgiati P, Bajo E, Bigelli M, De Ronchi D.
    World J Biol Psychiatry; 2011 Oct; 12(7):501-15. PubMed ID: 21595526
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Assessing the value of symptom relief for patients with gastroesophageal reflux disease treatment: willingness to pay using a discrete choice experiment.
    Deal K, Marshall D, Dabrowski D, Charter A, Bukoski M, Moayyedi P.
    Value Health; 2013 Jun; 16(4):588-98. PubMed ID: 23796293
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
    Ethgen O, Tancredi A, Lejeune E, Kvasz A, Zegels B, Reginster JY.
    J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A survey of prescribing preferences in the treatment of refractory depression: recent trends.
    Kornbluh R, Papakostas GI, Petersen T, Neault NB, Nierenberg AA, Rosenbaum JF, Fava M.
    Psychopharmacol Bull; 2001 Nov; 35(3):150-6. PubMed ID: 12397884
    [Abstract] [Full Text] [Related]

  • 13. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
    Smits KM, Smits LJ, Schouten JS, Peeters FP, Prins MH.
    Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of willingness to pay to study values for pharmacotherapies for migraine headache.
    Lenert LA.
    Med Care; 2003 Feb; 41(2):299-308. PubMed ID: 12555057
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Does the number of choice sets matter? Results from a web survey applying a discrete choice experiment.
    Bech M, Kjaer T, Lauridsen J.
    Health Econ; 2011 Mar; 20(3):273-86. PubMed ID: 20143304
    [Abstract] [Full Text] [Related]

  • 19. Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE).
    Najafzadeh M, Johnston KM, Peacock SJ, Connors JM, Marra MA, Lynd LD, Marra CA.
    BMC Health Serv Res; 2013 Oct 31; 13():454. PubMed ID: 24176050
    [Abstract] [Full Text] [Related]

  • 20. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.
    Marra CA, Esdaile JM, Anis AH.
    J Rheumatol; 2002 Dec 31; 29(12):2507-12. PubMed ID: 12465143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.